Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome by Bagchi, Debasis; Nair, Sreejayan;

Long description:

Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome, Second Edition, provides an overview of the current diabetes epidemic, outlines the consequences of this crisis, and lays out strategies to forestall and prevent diabetes, obesity and other intricate issues of metabolic syndrome. Contributing experts provide up-to-date global approaches to the critical consequences of metabolic syndrome and make the book an important reference for those working with the treatment, evaluation or public health planning for the effects of metabolic syndrome and diabetes.

Completely revised with 15 new chapters, the book includes coverage of the roles of gut microbiome in obesity and diabetes, macrovascular and microvascular complications, diabetes, metabolic syndrome and kidney disease, aspects of diabetic cardiomyopathy, diabetes, Alzheimer's and neurodegenerative diseases, roles of SGLT2 inhibitors in the treatment of type 2 diabetes, novel biomarkers in diabetes, roles of Trigonella foenum-graecumseed extract in type 2 diabetes, beneficial effects of chromium (III) and vanadium supplements in diabetes, prevention of type 1 diabetes, novel drugs in the therapeutic intervention of type 2 diabetes, eHealth and mobile apps for self-management, artificial pancreatic transplantation, non-invasive glucose monitoring, and the app for glucose regulation.

Table of Contents:

I. EPIDEMIOLOGY AND OVERVIEW
1. Type 1 Diabetes Mellitus: An Overview
SALEH ADI AND ANDREA GERARD GONZALEZ
2. Prediabetes: Prevalence, Pathogenesis, and Recognition of Enhanced Risk
ALOK K. GUPTA, AJAY MENON, MEGHAN BRASHEAR AND WILLIAM D. JOHNSON
3. Targeting Prediabetes to Preempt Diabetes
SREEDHARAN N, MAHADEV RAO AND SONAL SEKHAR M
4. Obesity and Type 2 Diabetes in Youths: New Challenges to Overcome
NICOLA SANTORO, COSIMO GIANNINI AND SONIA CAPRIO
5. Roles of Environmental Pollution and Pesticides in Diabetes and Obesity: The Epidemiological Evidence
CHARLES J. EVERETT, DANIRA MEDUNJANIN AND IVAR L. FRITHSEN
6. An Overview of the Roles of the Gut Microbiome in Obesity and Diabetes
GILLIAN M. BARLOW, EUGENIA A. LIN AND RUCHI MATHUR

II. TYPES OF DIABETES AND ITS CORRELATION WITH OTHER DISEASES
7. Role of Peripheral Neuropathy in the Development of Foot Ulceration and Impaired Wound Healing in Diabetes Mellitus
FRANCESCO TECILAZICH AND ARISTIDIS VEVES
8. The Association of Diabetes in the Onset of Dementia in the Elderly Population: An Overview
ABHAI KUMAR AND SMITA SINGH
9. The Role of Insulin Resistance in the Cardiorenal Syndrome
ADAM WHALEY-CONNELL AND JAMES R. SOWERS
10. An Overview on Diabetic Nephropathy
KEI FUKAMI AND SHO-ICHI YAMAGISHI
11. An Overview of Diabetic Retinopathy
SHINTARO NAKAO, SHIGEO YOSHIDA AND KOH-HEI SONODA
12. An Overview of Gestational Diabetes
CHRISTOPHER FEDERICO AND GABRIELLA PRIDJIAN
13. Diabetes, a Potential Threat to the Development and Progression of Tumor Cells in Individuals
SAYANTAN MAITRA, STABAK DAS AND PRADIPTA BANERJEE

III. MOLECULAR INSIGHTS OF DIABETES AND METABOLIC SYNDROME
14. Lipid-Induced Insulin Resistance: Molecular Mechanisms and Clinical Implications
SATINATH MUKHOPADHYAY, DEEP DUTTA AND DIPYAMAN GANGULY
15. Gene-Environment Interaction in the Pathogenesis of Type 2 Diabetes
KIAN-PENG GOH
16. Renal Sodium-Glucose Transporter-2 Inhibitors and Antidiabetic Agents
ANAND S. NAIR, DEBASIS BAGCHI AND SREEJAYAN NAIR
17. Emerging Role of MicroRNA in Diabetes Mellitus
ANAND S. NAIR AND DEBASIS BAGCHI

IV. PATHOPHYSIOLOGY
18. Insulin Resistance Syndrome: A Crucial Example Where a Physiological Continuum of Risks Needs Attention
HARRY G. PREUSS
19. Sleep Disturbances, Hypertension, and Type 2 Diabetes
MICHELLE A. MILLER AND FRANCESCO P. CAPPUCCIO
20. Roles of Pancreatic Cell Function, Liver, Skeletal Muscle, and Adipose Tissue in Diabetes and the Metabolic Syndrome
BEVERLY S. M-HLH-USLER
21. Glycemic Variability and Its Clinical Implications
NARSINGH VERMA
22. Diabetic Wound Inflammation
SCOTT CHAFFEE, AMITAVA DAS, SUMAN SANTRA AND SASHWATI ROY
23. Sarcopenia, Diabetes, and Nutritional Intervention
SHEILA M. WICKS, IVAN SALAMON, ANGELA I. CALDERON, ESPERANZA CARCACHE DE BLANCO AND GAIL B. MAHADY

V. PREVENTION AND TREATMENT 1: DIET, EXERCISE, SUPPLEMENTS AND ALTERNATIVE MEDICINES
24. Dietary Polyphenols, Gut Microbiota, and Intestinal Epithelial Health
MEIJUN ZHU
25. Reducing the Risk of Diabetes and Metabolic Syndrome With Exercise and Physical Activity
DAWN BLATT AND CHERI L. GOSTIC
26. Nutraceutical Impact on the Pathophysiology of Diabetes Mellitus
ODETE MENDES, LEE KOETZNER AND JAYSON CHEN
27. Therapeutic Effect of Fucoxanthin on Metabolic Syndrome and Type 2 Diabetes
KAZUO MIYASHITA, SHOW NISHIKAWA AND MASASHI HOSOKAWA
28. Safety and Antidiabetic Efficacy of a Novel Trigonella foenum-graecum Seed Extract
ANAND SWAROOP, MANASHI BAGCHI, HARRY G. PREUSS AND DEBASIS BAGCHI
29. Beneficial Effects of Chromium(III) and Vanadium Supplements in Diabetes
JOHN B. VINCENT
30. Protective Role of Alpha-Tocopherol in Diabetic Nephropathy
DAIKI HAYASHI AND YASUHITO SHIRAI
31. Antidiabetic Activity of Curcumin: Insight Into Its Mechanisms of Action
MARZENA WOJCIK, MICHAL KRAWCZYK AND LUCYNA A. WOZNIAK
32. Meal Plans for Diabetics: Caloric Intake, Calorie Counting, and Glycemic Index
PAULIN MOSZCZYNSKI AND ZBIGNIEW TABAROWSKI

VI. PREVENTION AND TREATMENT 2: DRUGS AND PHARMACEUTICALS
33. The Evolution of Glucose-Lowering Drugs for Type 2 Diabetes
ANDREW J. KRENTZ AND ALAN J. SINCLAIR
34. Current Antidiabetic Drugs: Review of Their Efficacy and Safety
MD. AKIL HOSSAIN AND ROKEYA PERVIN
35. HDACs in Diabetes: A New Era of Epigenetic Drug
LU-S F. SCH-TZ, MIN HI PARK AND MAHUA CHOUDHURY

VII. NOVEL INNOVATIONS
36. Noninvasive Blood Glucose Measurement
YASUHIRO UWADAIRA AND AKIFUMI IKEHATA

VIII. DIABETES IN ANIMALS AND TREATMENT
37. Diabetes Mellitus in Animals: Diagnosis and Treatment of Diabetes Mellitus in Dogs and CatsDEBORAH S. GRECO